8th Seattle Patient Conference - Leukemic Transformation | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

8th Seattle Patient Conference - Leukemic Transformation

Presenter(s): 
Topic(s): 
Related Bone Marrow Failure Diseases and Malignancies
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Sat, 06/26/2021 - 12:45pm (EDT)

Dr. Anna Halpern is a hematologist-oncologist and a clinical researcher. Her work focuses on hematologic (blood-based) malignancies — specifically, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), polycythemia vera, essential thrombocythemia and myelofibrosis. This session covers leukemic transformation which means when a bone marrow failure disease transitions to leukemia, usually AML.